09:50 AM EST - Avant Technologies Inc : Today announced the official launch of their joint venture, Klothonova LLC, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for innovative cell-based therapies to combat age-related diseases such as Alzheimer's and cancer, while also advancing anti-aging and longevity treatments. Avant Technologies Inc
shares O.AVAI are trading unchanged at $0.39.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=AVAI&qmodStoryID=5109695485872416
